Filing Flows › Myomo (MYO) › R&D spending
Myomo (MYO) R&D spending by quarter
Myomo's R&D spending was $1.7M in Q2 2026 (second quarter 2026), +6% from Q1 2026. Over the last 7 quarters it ranged from $1.5M (Q3 2025) to $2.0M (Q2 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $1.7M | +6% | -14% |
| Q1 2026 | $1.6M | -0.1% | -9% |
| Q4 2025 | $1.6M | +6% | +4% |
| Q3 2025 | $1.5M | -24% | — |
| Q2 2025 | $2.0M | +12% | — |
| Q1 2025 | $1.8M | +15% | — |
| Q4 2024 | $1.6M | — | — |
Q2 2026 at a glance
Myomo, Q2 2026: revenue $11.7M (+21% year over year), operating margin -19.3%, net loss $4.0M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Myomo's R&D spending?
Myomo's R&D spending was $1.7M in Q2 2026 (second quarter 2026), +6% from Q1 2026.
How has Myomo's R&D spending changed?
Over the last 7 quarters it ranged from $1.5M (Q3 2025) to $2.0M (Q2 2025).